[ad_1]
Houston, August 10, 2022 /PRNewswire/ — Melax Tech, A world leader in biomedical natural language processing (NLP) technology announced today that it has received a Phase I SBIR award for a project focused on real-time tracking of vaccine misinformation from social media platforms using ontology and NLP..
A Tier One SBIR grant, worth it 300,000 dollarsAwarded by the National Institute of Allergy and Infectious Diseases (NIAID) for developing innovative and rigorous computational algorithms, including semantic technologies and NLP algorithms, to capture, extract, and synthesize vaccine misinformation from multiple popular social media sources.
“This is a very real topic that is currently affecting culture and it shows that we as a joint business and a group of experts are at the cutting edge of science in the field of NLP and AI,” he said. Andre PontinCEO of Melax Tech
Dr. Jingcheng DuAccording to the NLP research director at Melax Tech, “The main driver for vaccine hesitancy is widespread and uncontrolled vaccine misinformation. As the first of its kind, we will build deep learning-based NLP algorithms to extract and normalize vaccine misinformation from social media. We will also provide the wider community We will be creating an interactive visualization to synthesize vaccine misinformation in an understandable way to engage.We are excited about this project and its potential to improve public health.
About Melax Tech
Melax Tech encourages businesses, laboratories and other life science organizations to use natural language processing (NLP) technology to unlock unstructured text data. Our customers use our AI-powered software to gain insights, make decisions and analyze findings. With a team with over 20 years of experience in developing clinical NLP technology, Melax Tech has been ranked first in dozens of international NLP tests. This award-winning software is used in computer-aided medical coding, clinical decision support, monitoring, quality of care, patient safety reporting and client-defined projects.
For more information about Melax Tech’s innovative solutions, visit the company’s website.
See original content: https://www.prnewswire.com/news-releases/melax-tech-receives-niaid-award-to-develop-real-time-surveillance-of-vaccine-misinformation-from-social-media- forums-301603637.html
Source Melax Technologies, Inc.
[ad_2]
Source link
